Combinatory action of chitosan-based blended films and loaded cajeput oil against Staphylococcus aureus and Pseudomonas aeruginosa-mediated infections

• Autor(a) principal: Antunes, Joana Isabel Costa
• Data de Publicação: 2020
• Outros Autores: Tavares, Tânia Daniela Eugénio, Homem, Natália Cândido, Teixeira, Marta A., Amorim, M. T. Pessoa de, Felgueiras, Helena Prado
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/1822/70193
• topic: Bactericidal; Marine-derived polymers; Natural bioactive agents; Drug delivery systems; Blended films; Engenharia e Tecnologia::Engenharia dos Materiais; Saúde de qualidade

Chronic wounds (CW) have numerous entry ways for pathogen invasion and prosperity, damaging host tissue and hindering tissue remodeling. Essential oils exert quick and efficient antimicrobial (AM) action, unlikely to induce bacterial resistance. Cajeput oil (CJO) has strong AM properties, namely against Staphylococcus aureus and Pseudomonas aeruginosa. Chitosan (CS) is a natural and biodegradable cationic polysaccharide, also widely known for its AM features. CS and poly(vinyl alcohol) (PVA) films were prepared (ratio 30/70; 9 wt%) by solvent casting and phase inversion method. Films’ thermal stability and chemical composition data reinforce polymer blending. Films were supplemented with 1 and 10 wt% of CJO in relation to total polymeric mass. Loaded films were 23 and 57% thicker, respectively, than the unloaded films. Degree of swelling and porosity also increased, particularly with 10 wt% CJO. AM testing revealed that CS films alone were effective against both bacteria, eradicating all P. aeruginosa within the hour (*** p < 0.001). Still, loaded CS/PVA films showed improved AM traits, being significantly more efficient than unloaded films right after 2 h of contact. This study is the first proof of concept that CJO can be dispersed into CS/PVA films and show bactericidal effects, particularly against P. aeruginosa, this way opening new avenues for CW therapeutics.